REFERENCES
- Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens‐Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev 2008; 7: 598–605.
- Sotozono C, Ang LP, Koizumi N, Higashihara H, Ueta M, Inatomi T, Yokoi N et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens‐Johnson syndrome. Ophthalmology 2007; 114: 1294–1302.
- Shammas MC, Lai EC, Sarkar JS, Yang J, Starr CE, Sippel KC. Management of acute Stevens‐Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids. Am J Ophthalmol 2010; 149: 203–213.
- Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM. Erythema multiforme, Stevens‐Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes and management. Cornea 2007; 26: 123–129.
- Shay E, Kheirkhah A, Liang L, Sheha H, Gregory DG, Tseng SC. Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens‐Johnson syndrome and toxic epidermal necrolysis. Surv Ophthalmol 2009; 54: 686–696.
- Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M. Risk factors for the development of ocular complications of Stevens‐Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 2009; 145: 157–162.
- Thong BY. Update on the management of antibiotic allergy. Allergy Asthma Immunol Res 2010; 2: 77–86.
- Chia FL, Leong KP. Severe cutaneous adverse reactions to drugs. Curr Opin Allergy Clin Immunol 2007; 7: 304–309.